- Home
- ITT vs ROIV Comparison
ITT vs ROIV Comparison
Compare ITT & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITT | ROIV |
|---|---|---|
| Founded | 1920 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 15.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ITT | ROIV |
|---|---|---|
| Price | $201.76 | $21.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $205.56 | $24.31 |
| AVG Volume (30 Days) | 813.6K | ★ 5.6M |
| Earning Date | 02-05-2026 | 02-06-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.11 | N/A |
| Revenue | ★ $3,938,500,000.00 | $13,310,000.00 |
| Revenue This Year | $8.08 | N/A |
| Revenue Next Year | $8.13 | $741.42 |
| P/E Ratio | $33.08 | ★ N/A |
| Revenue Growth | ★ 8.48 | N/A |
| 52 Week Low | $105.64 | $8.73 |
| 52 Week High | $205.71 | $23.91 |
Technical Indicators
Market Signals| Indicator | ITT | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 73.32 | 66.92 |
| Support Level | $178.08 | $20.99 |
| Resistance Level | $205.71 | $22.49 |
| Average True Range (ATR) | 4.98 | 0.67 |
| MACD | 1.81 | 0.00 |
| Stochastic Oscillator | 88.27 | 95.62 |
Price Performance
Historical ComparisonAbout ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.